The Effect of Genetic Polymorphisms on the Success of Vital Pulp Therapy
Condition(s) studied
Investigational drug(s) / intervention(s)
Biodentine: Biodentine is used in the treatment of existing dentin damage thanks to active bio-silicate technology.
Study summary
This study employs saliva-based DNA analysis to investigate the effect of genetic polymorphisms, particularly SNPs in MMP, TIMP, TNF-α, and BMP genes, on the success of vital pulp therapy in permanent teeth with pulpitis, assessed through clinical follow-up.
Eligibility
Primary outcome measure(s)
- DNA Analysis — From enrollment to the end DNA analysis at 18 months
After treatment, patients will undergo clinical and radiographic evaluations at the 6th and 12th months. Treatments will be considered successful if the patient reports no complaints during follow-up; if clinical examination reveals no hypersensitivity to thermal stimuli, gingival swelling, sinus tract, mobility, or sensitivity to lateral and vertical percussion; and if radiographic examination shows no periradicular changes, root resorption, irregular calcification within the canal, and evidence of a radiopaque dentin bridge formation.After the 12-month follow-up period, the data obtained will be categorized according to patients' genetic profiles (i.e., polymorphism types), and the relationship between vital pulp therapy success and genetic polymorphism will be evaluated.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Ataturk University | Erzurum | Turkey (Türkiye) |
More Ataturk University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07130214 on ClinicalTrials.gov ↗ ← All trials in Turkey